NeoTX successfully completes 1st stage of PIIa trial of NAP+docetaxel in NSCLC
01 Jun 2022 //
PRNEWSWIRE
NeoTX to Present at the Society for Immunotherapy Cancer`s 36th Annual Meeting
09 Nov 2021 //
PRNEWSWIRE
NeoTX Announces First Patient Enrolled In Phase 2a Clinical Trial Of (NAP)
20 Oct 2021 //
PRNEWSWIRE
NeoTX Hosting KOL Webinar on Overcoming Check Point Inhibitor Resistance
07 Jul 2021 //
GLOBENEWSWIRE
US FDA clears NeoTX’s IND application for ph 2 trial of naptumomab estafenatox
20 Apr 2021 //
PRESS RELEASE